Evidence map›Paper›PMID 30081223›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2019

Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening.

Sarmed S Sami, Prasad G Iyer, Prachi Pophali, Magnus Halland, Massimiliano di Pietro, Jacobo Ortiz-Fernandez-Sordo, Jonathan R White, Michele Johnson, Indra Neil Guha, Rebecca C Fitzgerald and 1 more

Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02066233 (Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy), which is not on this map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02066233 nacompletednot on this map

Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy

TypeinterventionalSponsorMayo ClinicRan2014 to 2016Enrolled100ConditionsBarrett's EsophagusArmsEG Scan II (transnasal endoscopy), Standard Endoscopy
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Unsedated transnasal endoscopy for the detection of Barrett's esophagus: systematic review and meta-analysis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2023
    Pooled it
  4. Article
  5. Review
  6. Improving esophageal cancer screening across the globe: Translating knowledge into action.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  13. Screening for Barrett's Oesophagus: Are We Ready for it?Current treatment options in gastroenterology · 2021
    Review
  14. Review
  15. Review
  16. Novel Screening Alternatives for Barrett Esophagus.Gastroenterology & hepatology · 2020
    Article
  17. Article
  18. Miniature gastrointestinal endoscopy: Now and the future.World journal of gastroenterology · 2019
    Review
  19. Novel Screening Tests for Barrett's Esophagus.Current gastroenterology reports · 2019
    Review
  20. Is Mass Screening for Barrett's Esophagus a Myth or Reality?Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Sarmed S SamiBarrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota; Division of Surgery and Interventional Science, University College London, London, United Kingdom.
Prasad G IyerBarrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota.
Prachi PophaliBarrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota.
Magnus HallandBarrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota.
Massimiliano di PietroCambridge University Hospitals NHS Trust and MRC Cancer Unit, Hutchinson/MRC Research Center, University of Cambridge, Cambridge, United Kingdom.
Jacobo Ortiz-Fernandez-SordoNational Institute for Health Research Biomedical Research Center in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham, Queens Medical Center Campus, Nottingham, United Kingdom.
Jonathan R WhiteNational Institute for Health Research Biomedical Research Center in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham, Queens Medical Center Campus, Nottingham, United Kingdom.
Michele JohnsonBarrett's Esophagus Unit, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota.
Indra Neil GuhaNational Institute for Health Research Biomedical Research Center in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham, Queens Medical Center Campus, Nottingham, United Kingdom.
Rebecca C FitzgeraldCambridge University Hospitals NHS Trust and MRC Cancer Unit, Hutchinson/MRC Research Center, University of Cambridge, Cambridge, United Kingdom.
Krish RagunathNational Institute for Health Research Biomedical Research Center in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham, Queens Medical Center Campus, Nottingham, United Kingdom. Electronic address: k.ragunath@nottingham.ac.uk.
Mayo Clinic in Florida · USNational Institute for Health Research · GBMRC Cancer Unit · GBQueen's Medical Centre · GBUniversity College London · GBUniversity of Cambridge · GB

Funding

Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Medical Research Council MC_UU_12022/2NCI NIH HHS U54 CA163060
6 · The paper itself

Abstract

BACKGROUND &

aimsScreening for Barrett's esophagus (BE) with conventional esophagogastroduodenoscopy (C-EGD) is expensive. We assessed the performance of a clinic-based, single use transnasal capsule endoscope (EG Scan II) for the detection of BE, compared to C-EGD as the reference standard.

methodsWe performed a prospective multicenter cohort study of patients with and without BE recruited from 3 referral centers (1 in the United States and 2 in the United Kingdom). Of 200 consenting participants, 178 (89%) completed both procedures (11% failed EG Scan due to the inability to intubate the nasopharynx). The mean age of participants was 57.9 years and 67% were male. The prevalence of BE was 53%. All subjects underwent the 2 procedures on the same day, performed by blinded endoscopists. Patients completed preference and validated tolerability (10-point visual analogue scale [VAS]) questionnaires within 14 days of the procedures.

resultsA higher proportion of patients preferred the EG Scan (54.2%) vs the C-EGD (16.7%) (P < .001) and the EG Scan had a higher VAS score (7.2) vs the C-EGD (6.4) (P = .0004). No serious adverse events occurred. The EG Scan identified any length BE with a sensitivity value of 0.90 (95% CI, 0.83-0.96) and a specificity value of 0.91 (95% CI, 0.82-0.96). The EG Scan identified long segment BE with a sensitivity value of 0.95 and short segment BE with a sensitivity values of 0.87.

conclusionsIn a prospective study, we found the EG Scan to be safe and to detect BE with higher than 90% sensitivity and specificity. A higher proportion of patients preferred the EG Scan to C-EGD. This device might be used as a clinic-based tool to screen populations at risk for BE. ISRCTN registry identifier: 70595405; ClinicalTrials.gov no: NCT02066233.

Indexed as

AdultAgedAged, 80 and overBarrett EsophagusCapsule EndoscopyFemaleHumansMaleMass ScreeningMiddle AgedPatient Acceptance of Health CarePatient SafetyProspective StudiesSensitivity and SpecificityUnited KingdomUnited StatesEsophageal AdenocarcinomaImagingOfficePortableReflux

Identifiers

PMID30081223
PMCPMC6330075
OpenAlexW2885436196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.